MURA, Antonio
MURA, Antonio
MEDICINA, CHIRURGIA E FARMACIA
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes
2022-01-01 Galleri, P.; Lazzarato, A.; Sanna, C.; Mura, A.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study
2024-01-01 Nuvoli, S.; Fiorillo, E.; Mura, A.; Piras, M. R.; Sanna, C.; Marongiu, A.; Marongiu, M.; Lobina, M.; Orrù, V.; Piras, M. G.; Madeddu, G.; Spanu, A.; Cucca., F.
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage.
2024-01-01 Marongiu, Andrea; Galleri, Paolo; Papaleo, Antonio; Mura, Antonio; Madeddu, Giuseppe; Spanu, Angela; Solla, Paolo; Nuvoli, Susanna.
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia
2022-01-01 Sanna, C.; Lazzarato, A.; Galleri, P.; Marongiu, A.; Mura, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli, S.
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC)
2024-01-01 Marongiu, A.; Nuvoli, S.; De Vito, A.; Falchi, A.; Vargiu, S.; Mura, A.; Spanu, A.; Madeddu., G.
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?
2024-01-01 Dondi, Francesco; Miceli, Alberto; Rovera, Guido; Feudo, Vanessa; Battisti, Claudia; Rondini, Maria; Marongiu, Andrea; Mura, Antonio; Camedda, Riccardo; Silvia De Feo, Maria; Conte, Miriam; Gorica, Joana; Ferrari, Cristina; Giulia Nappi, Anna; Santo, Giulia
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up
2024-01-01 Marongiu, Andrea; Nuvoli, Susanna; De Vito, Andrea; Mura, Antonio; Vargiu, Sonia; Spanu, Angela; Madeddu, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes | 1-gen-2022 | Galleri, P.; Lazzarato, A.; Sanna, C.; Mura, A.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G. | |
| 18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study | 1-gen-2024 | Nuvoli, S.; Fiorillo, E.; Mura, A.; Piras, M. R.; Sanna, C.; Marongiu, A.; Marongiu, M.; Lobina, M.; Orrù, V.; Piras, M. G.; Madeddu, G.; Spanu, A.; Cucca., F. | |
| 18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. | 1-gen-2024 | Marongiu, Andrea; Galleri, Paolo; Papaleo, Antonio; Mura, Antonio; Madeddu, Giuseppe; Spanu, Angela; Solla, Paolo; Nuvoli, Susanna. | |
| Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia | 1-gen-2022 | Sanna, C.; Lazzarato, A.; Galleri, P.; Marongiu, A.; Mura, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli, S. | |
| Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) | 1-gen-2024 | Marongiu, A.; Nuvoli, S.; De Vito, A.; Falchi, A.; Vargiu, S.; Mura, A.; Spanu, A.; Madeddu., G. | |
| Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? | 1-gen-2024 | Dondi, Francesco; Miceli, Alberto; Rovera, Guido; Feudo, Vanessa; Battisti, Claudia; Rondini, Maria; Marongiu, Andrea; Mura, Antonio; Camedda, Riccardo; Silvia De Feo, Maria; Conte, Miriam; Gorica, Joana; Ferrari, Cristina; Giulia Nappi, Anna; Santo, Giulia | |
| The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up | 1-gen-2024 | Marongiu, Andrea; Nuvoli, Susanna; De Vito, Andrea; Mura, Antonio; Vargiu, Sonia; Spanu, Angela; Madeddu, Giuseppe |